Spironolactone Tablets (Greenstone LLC)

Hazard statements (CLP)

H351, H360D, H373

Code

Statements

H351

Suspected of causing cancer

2.1 Classification of the substance or mixture

Reproductive Toxicity: Category 1B Carcinogenicity: Category 2 Specific target organ systemic toxicity (repeated exposure): Category 2

EU Classification

EU Indication of danger Toxic to Reproduction Category 2 Carcinogenic: Category 3 Harmful EU Risk Phrases: R40 - Limited evidence of a carcinogenic effect R48/22 - Harmful: danger of serious damage to health by prolonged exposure if swallowed. R61 - May cause harm to the unborn child.

Signal word

Danger

Hazard statements

H351 - Suspected of causing cancer H373 - May cause damage to organs through prolonged or repeated exposure H360D - May damage the unborn child

Precautionary statements

P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P260 - Do not breathe dust/fume/gas/mist/vapors/spray P281 - Use personal protective equipment as required P308 + P313 - IF exposed or concerned: Get medical attention/advice P314 - Get medical attention/advice if you feel unwell P405 - Store locked up P501 - Dispose of contents/container in accordance with all local and national regulations

2.3 Other hazards

No data available Australian Hazard Classification

Hazardous Ingredients

Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which requires the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warning included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.